NEXAVIR
Approved
Approval ID
06af24a7-5779-4ef9-a066-b78b52898457
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 19, 2020
Manufacturers
FDA
Nexco Pharma
DUNS: 023524538
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
liver derivative complex
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10530-319
Product Classification
G
Generic Name
liver derivative complex
Product Specifications
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS
Effective DateFebruary 19, 2020
FDA Product Classification
INGREDIENTS (5)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PHENOLInactive
Code: 339NCG44TV
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PORK LIVERActive
Quantity: 25.5 mg in 1 mL
Code: 6EC706HI7F
Classification: ACTIB